HOME >> BIOLOGY >> NEWS
Tracking A Killer's Progression

Researchers at the University of Kentucky report today the discovery a novel attack route used by one of the plague bacterium's killer toxins. Their work with Yersinia pestis, the bacterium which causes the plague, is published in the Nov. 28 issue of Molecular Microbiology. The study provides new clues about how a toxic protein called YopM, originally discovered at UK, targets and attacks the cell's nucleus. Only two other pathogenic bacterial proteins are known to enter the nucleus of cells.

"This finding raises the intriguing possibility that YopM may contribute to the development of disease by altering human gene expression," said Susan Straley, Ph.D., professor of microbiology and immunology, UK College of Medicine, and director of the research team for the project. "We believe that further study of the mode of action of this protein in host cells will provide insight into bacterial causes of disease and cell biology."

Yersinia invades an organism and attaches itself to cell surfaces. YopM is one of six toxins called Yops that Yersinia injects directly into the cell. Yops act by scrambling the functions necessary for humans to mount a defense against the bacteria.

Little is known about how these mysterious toxins function to destroy the immune response, but researchers believe Yops target phagocytic cells, the body's first line of defense against invaders. The bacterial killing response of the phagocytic cells is paralyzed, and the cells are rendered incapable of sending messages to other cells to begin an immune response to the pathogen.

UK researchers propose that YopM uses complex interactions to reach and pass through the controlled gates of the nucleus. They believe YopM binds to the exterior of acidic compartments, called endosomal vesicles, and moves as new vesicles arise. YopM may act to prevent enter the nucleus by itself or it may become associated with a protein. Once the nucleus is invaded, YopM
'"/>

Contact: Vikki Franklin
vyfran0@pop.uky.edu
606-323-6363
University of Kentucky Medical Center
28-Nov-1998


Page: 1 2

Related biology news :

1. Tracking climate change
2. Tracking cystic fibrosis with mice
3. Tracking the illegal ivory trade
4. Tracking every egg? AAAS report lists practical options for regulating human cloning
5. School of public health launches CDC Center for Excellence in Environmental Public Health Tracking
6. Satellites vs. mosquitoes: Tracking West Nile Virus in the U.S.
7. Tracking and treating toxic waste in urban neighborhoods
8. Tracking path of virulent bacteria via the web
9. Tracking a genetic basis for alcohol-related hypertension
10. Fat In Spite Of Hard Farm Work - Tracking Down Obesity
11. Tracking A Legacy Of Waste In The West Siberian Basin

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Tracking Killer Progression

(Date:5/22/2013)... and engineers must join together in a major new ... a crisis in providing Earth,s people with clean water ... focus of a comment article in the current edition ... newsmagazine of the American Chemical Society (ACS), the world,s ... L. Sedlak, Ph.D., and Jerald L. Schnoor, Ph.D., explain ...
(Date:5/22/2013)... engineering drastically reduces the time and effort needed ... of biotechnology, scientists are reporting. Published in the ... paves the way for more rapid development of ... other activities. , Keith Shearwin and colleagues explain ... genetic material DNA into a bacterium,s genome is ...
(Date:5/22/2013)... Adventitious changes in cellular DNA can endanger the whole ... cancer. Researchers at Ludwig-Maximilians-Universitaet (LMU) in Munich now report ... the double helix. , The DNA in our cells ... in our bodies. The instructions for this are encoded ... in DNA, the bases adenine (A), cytosine (C), guanine ...
Breaking Biology News(10 mins):DNA damage: The dark side of respiration 2
(Date:5/23/2013)... PuraMed BioScience ® , Inc., (OTCBB: ... (OTC) medicinal and healthcare products, announced that Ludlow ... based on low market capitalization valuation. ... Product to Treat Migraine Headaches , Clinical ... , Currently Available Nationwide at Walgreen,s and ...
(Date:5/23/2013)... , May 23, 2013  Saddleback Memorial Medical ... recently became the first hospital on the West Coast ... This new surgical option provides women with a state-of-the-art, ... Marc Winter , M.D., a highly ... surgeon and medical director of minimally invasive surgery at ...
(Date:5/23/2013)... -- Northwest Biotherapeutics (NASDAQ: NWBO ) (NW ... immune therapies for solid tumor cancers, announced today that ... Society Of Clinical Oncology (ASCO) meeting in ... immune therapy.  (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO ) ... conference focused on clinical treatment of cancer, with attendance ...
(Date:5/23/2013)... BUSAN, South Korea , May 23, 2013 ... collaboration with SillaJen, Inc., a private biotherapeutics and ... of targeted biological products for cancer, announced today ... antibodies in patients treated with the oncolytic and ... This research was published in the ...
Breaking Biology Technology:PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 3
Cached News: